Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 202-088-8 | CAS number: 91-66-7
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Acute oral toxicity:
The acute oral toxicity dose (LD50) was considered based on different studies conducted on rats for the test chemical. The LD50 value is between 300-2000 mg/kg bw, for acute oral toxicity. Thus, comparing this value with the criteria of CLP regulation, the given test chemical can be classified for acute oral toxicity class IV.
Acute Inhalation Toxicity:
The acute inhalation toxicity dose (LC50) was considered based on different studies conducted on rats and mice for the test chemical. The LC50 value is between 500-2500 ppm, for acute inhalation toxicity. Thus, comparing this value with the criteria of CLP regulation, the given test chemical can be classified for acute inhalation toxicity class III.
Acute Dermal toxicity:
The acute dermal toxicity dose (LD50) was considered based on different studies conducted on rats and rabbits for the test chemical. The studies concluded that LD50 value is between 200-1000 mg/kg bw, for acute dermal toxicity. Thus, comparing this value with the criteria of CLP regulation, the given test chemical can be classified for acute dermal toxicity class III.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Justification for type of information:
- Data is from authoritative database
- Qualifier:
- according to guideline
- Guideline:
- other: As mentioned below
- Principles of method if other than guideline:
- Acute oral toxicity of test chemical in rats
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Species:
- rat
- Strain:
- not specified
- Sex:
- not specified
- Route of administration:
- oral: unspecified
- Vehicle:
- not specified
- Details on oral exposure:
- not reported
- Doses:
- 782 mg/kg bw
- No. of animals per sex per dose:
- not reported
- Control animals:
- not specified
- Details on study design:
- not reported
- Statistics:
- not reported
- Preliminary study:
- not reported
- Key result
- Sex:
- not specified
- Dose descriptor:
- LD50
- Effect level:
- 782 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other:
- Remarks:
- 50% mortality observed
- Mortality:
- 50% mortality observed at 782 mg/kg bw dose
- Clinical signs:
- other: not reported
- Gross pathology:
- not reported
- Other findings:
- not reported
- Interpretation of results:
- Toxicity Category IV
- Conclusions:
- The Lethal concentration value for 50 percent mortality (LD 50) in rats by the oral administration of test chemical was reported to be 782 mg/kg body weight.
- Executive summary:
Acute oral toxicity study of test chemical was conducted on rats at the dose concentration of 782 mg/kg bw. The test chemical was administered via oral unspeciified route. All animals were maintained under close observation for recording toxic signs and time of death for 14 days. 50% mortality was observed at 782 mg/kg bw. Therefore, LD50 value was considered to be 782 mg/kg bw, when rats were treated with test chemical via oral route..
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 782 mg/kg bw
- Quality of whole database:
- Data is Klimisch 2 and from authoritative database
Acute toxicity: via inhalation route
Link to relevant study records
- Endpoint:
- acute toxicity: inhalation
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 4 (not assignable)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Justification for type of information:
- Data is from publication
- Qualifier:
- according to guideline
- Guideline:
- other: As mentioned below
- Principles of method if other than guideline:
- Acute inhalation toxicity of test chemical in mice
- GLP compliance:
- not specified
- Test type:
- fixed concentration procedure
- Limit test:
- no
- Species:
- rat
- Strain:
- not specified
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- Not available
- Route of administration:
- inhalation
- Type of inhalation exposure:
- head only
- Vehicle:
- not specified
- Details on inhalation exposure:
- Details not available
- Duration of exposure:
- 4 h
- Concentrations:
- 533ppm, 644 ppm, 782 ppm, and 923 ppm
- No. of animals per sex per dose:
- 10 male rats each dose.
- Control animals:
- not specified
- Details on study design:
- Not specified
- Statistics:
- Not specified
- Sex:
- male
- Dose descriptor:
- LC50
- Effect level:
- 4.14 mg/L air
- Based on:
- test mat.
- Exp. duration:
- 4 h
- Remarks on result:
- other: 679 ppm equal to 4144.538 mg/m3
- Mortality:
- 533 ppm (2/10), 644 ppm (6/10), 782ppm (5/10), AND 923ppm (9/10).
- Clinical signs:
- other: CLINICAL SIGNS DURING AND IMMEDIATELY AFTER EXPOSURE INCLUDED: CYANOSIS, TREMORS, SEMIPROSTRATION, REDDISHBROWN NASAL DISCHARGE, HIND IMB ATAXIA, SALIVATION, AND ABNORMAL ARCHED BACK POSTURE. SIGNS OBSERVED AFTER 24 HOURS INCLUDED: STAINED PERINEAL AREA,
- Body weight:
- WEIGHT LOSS WAS OBSERVED 13 DAYS AFTER EXPOSURE; THEREAFTER NORMAL WEIGHT GAIN WAS SEEN.
- Gross pathology:
- Not specified
- Other findings:
- Not specified
- Interpretation of results:
- Toxicity Category III
- Conclusions:
- Acute inhalation toxicity in male rats was reported to be 679 ppm(4144.538 mg/m3 =4.144 mg/L).
- Executive summary:
- Acute inhalation toxicity for test chemical was studied in male rats. male rats(head only) were exposed for a single 4 hour period at a concentration of 533ppm, 644 ppm, 782 ppm, and 923 ppm. Clinical signs during and immediately after exposure included cyanosis, tremors, semi prostration, reddish brown nasal discharge, hind limb ataxia, salivation, and abnormal arched back posture. Signs observed after 24 hours included: stained perineal area, pallor, and reddish brown nasal discharge. Thus, LC 50 value was reported to be 679 ppm(4144.538 mg/m3=4.144 mg/l)
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LC50
- Value:
- 4 144.43 mg/m³ air
- Quality of whole database:
- Data is Klimisch 2 and from authoritative database
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- data from handbook or collection of data
- Justification for type of information:
- Data is from secondary source
- Qualifier:
- according to guideline
- Guideline:
- other: As mentioned below
- Principles of method if other than guideline:
- Acute dermal toxicity of test chemical in rabbits
- GLP compliance:
- not specified
- Test type:
- standard acute method
- Limit test:
- no
- Species:
- rabbit
- Strain:
- not specified
- Sex:
- not specified
- Details on test animals or test system and environmental conditions:
- not specified
- Type of coverage:
- not specified
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- not specified
- Duration of exposure:
- Exposure period unspecified
- Doses:
- 468 and 935 mg/kg-bw
- No. of animals per sex per dose:
- 4/dose
- Control animals:
- not specified
- Details on study design:
- not specified
- Statistics:
- not specified
- Sex:
- not specified
- Dose descriptor:
- LD0
- Effect level:
- 468 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: No mortality
- Sex:
- not specified
- Dose descriptor:
- LD100
- Effect level:
- 935 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: 100 % mortality
- Mortality:
- No mortalities occurred at 468 mg/kg-bw and all animals died at 935 mg/kg-bw.
- Clinical signs:
- other: not specified
- Gross pathology:
- not specified
- Other findings:
- not specified
- Interpretation of results:
- Toxicity Category III
- Conclusions:
- The acute dermal LD50 value was considered to be <935 mg/kg bw when rabbits were treated with test chemical via dermal route.
- Executive summary:
Acute dermal toxicity study test chemicalwas conducted on rabbits at the dose concentration of 468 and 935 mg/kg bw. The test chemical was administered via dermal route. All animals were maintained under close observation for recording toxic signs and time of death for 14 days.No mortalities were observed at 468 mg/kg-bw and all animals died at 935 mg/kg-bw. Thus the Lethal dose, 50 percent kill value (LD50) of test chemical for dermal toxicity in rabbit in between 468 and 935 mg/kg bw. This value suggests that test chemical is toxic by the dermal route and will be classified in category 3 for acute dermal toxicity. (LD0 is used for classification instead of LD50)
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 935 mg/kg bw
- Quality of whole database:
- Data is Klimisch 2 and from authoritative database
Additional information
Acute oral toxicity:
In different studies, the given test chemical has been investigated for acute oral toxicity to a greater or lesser extent. Often are the studies based on in-vivo experiments in rodents, i.e. most commonly in rats for test chemical. The studies are summarized as below –
1 Acute oral toxicity study of test chemical was conducted on rats at the dose concentration of 782 mg/kg bw. The test chemical was administered via oral unspecified route. All animals were maintained under close observation for recording toxic signs and time of death for 14 days. 50% mortality was observed at 782 mg/kg bw. Therefore, LD50 value was considered to be 782 mg/kg bw, when rats were treated with test chemical via oral route.
2. Acute oral toxicity study of test chemical was conducted on rats at the dose concentration of 720 mg/kg bw. The test chemical was administered via oral unspecified route. All animals were maintained under close observation for recording toxic signs and time of death for 14 days. Therefore, LD50 value was considered to be 720 mg/kg bw, when rats were treated with test chemical via oral route.
3. Acute oral toxicity study of test chemical was conducted on rats at the dose concentration of 100, 500, 600, 700 and 800 mg/kg-bw mg/kg bw. The test chemical was administered via oral gavage route. All animals were maintained under close observation for recording toxic signs and time of death for 14 days. There were no mortalities at 100 mg/kg-bw, one at 500 mg/kg-bw, two at 600 mg/kg-bw and six at 700 mg/kg-bw; all animals died at 800 mg/kg-bw. Clinical signs like Cyanosis, palmospasms, disorders of balance, increased diuresis, impaired general condition were observed. Therefore, LD50 value was considered to be 606 mg/kg bw, when rats were treated with test chemical via oral route.
Thus, based on the above summarised studies on test chemical, it can be concluded that LD50 value is between 300-2000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, the given test chemical can be classified for acute oral toxicity class IV.
Acute Inhalation Toxicity:
In different studies, the given test chemical has been investigated for acute inhalation toxicity to a greater or lesser extent. Often are the studies based on in-vivo experiments in rodents, i.e. most commonly in rats for test chemical. The studies are summarized as below –
1. Acute inhalation toxicity for test chemical was studied in male rats. male rats(head only) were exposed for a single 4 hour period at a concentration of 533ppm, 644 ppm, 782 ppm, and 923 ppm. Clinical signs during and immediately after exposure included cyanosis, tremors, semi prostration, reddish brown nasal discharge, hind limb ataxia, salivation, and abnormal arched back posture. Signs observed after 24 hours included: stained perineal area, pallor, and reddish brown nasal discharge. Thus, LC 50 value was reported to be 679 ppm(4144.538 mg/m3=4.144 mg/l)
2. The Lethal concentration, 50 percent mortality value (LC50) of test chemical for inhalation toxicity in rat was reported as 1.92 mg/L in a four hour exposure. This value suggests that test chemical is toxic by the inhalation route and will be classified in category 2 for acute inhalation toxicity.
3. The acute LC50 of test chemical was 4.3 mg/L. when based on nominal chamber concentration and 1.92 mg/L when based on average actual chamber concentration. The upper and lower 95% confidence intervals were 4.8 mg/L to 3.7 mg/L (nominal) and 2.10 mg/L to 1.84 mg/L (actu.al), respectively. Daily observations indicated the presence of ataxia and tremors in animals exposed to nominal concentrations of 5.2 mg/L or greater of test article. In addition, at this concentration, nasal discharge and decreased body weights were evident post exposure. Thus, LC50 value was considered to be 1920 mg/L bw, when rats were treated with test chemical.
Thus, based on the above summarized studies on test chemical, it can be concluded that LC50 value is between 500-2500 ppm. Thus, comparing this value with the criteria of CLP regulation, the given test chemical can be classified for acute inhalation toxicity class III.
Acute Dermal Toxicity:
In different studies, the given test chemical has been investigated for acute dermal toxicity to a greater or lesser extent. Often are the studies based on in-vivo experiments in rodents, i.e. most commonly in rats and rabbits for test chemical. The studies are summarized as below –
1 Acute dermal toxicity study test chemicalwas conducted on rabbits at the dose concentration of 468 and 935 mg/kg bw. The test chemical was administered via dermal route. All animals were maintained under close observation for recording toxic signs and time of death for 14 days.No mortalities were observed at 468 mg/kg-bw and all animals died at 935 mg/kg-bw. Thus the Lethal dose, 50 percent kill value (LD50) of test chemical for dermal toxicity in rabbit in between 468 and 935 mg/kg bw. This value suggests that test chemical is toxic by the dermal route and will be classified in category 3 for acute dermal toxicity. (LD0 is used for classification instead of LD50)
2. Acute dermal toxicity study oftest chemicalwas conducted on rabbits at the dose concentration of >5000 mg/kg bw. The test chemical was administered via dermal route. All animals were maintained under close observation for recording toxic signs and time of death for 14 days. Therefore, LD50 value was considered to be >5000 mg/kg bw, when rabbits were treated with test chemical via dermal route.
3. Acute dermal toxicity study of test chemical was conducted on rabbits at the dose concentration of >400 mg/kg bw. The test chemical was administered via dermal route. All animals were maintained under close observation for recording toxic signs and time of death for 14 days.Therefore, LD50 value was considered to be >400 mg/kg bw, when rabbits were treated with test chemical via dermal route.
4. Acute dermal toxicity study of test chemical was conducted on 4 groups of male and female New Zealand white rabbits at the dose concentration of 100, 215 464 and 1000 mg/kg bw. The test chemical was administered occlusive. All animals were maintained under close observation for recording toxic signs and time of death for 14 days. Mortality was observed at a dose level of 215, 464 and 1000 mg/kg bw. Body weight changes were observed and systemic toxicity signs like excessive salivation, eyes exceptionally blue and partially closed, depression, diarrhea, nasal discharge were observed during 14 days observation period. Gross necropsy signs like externally, a sac-like protrusion in the genital area were observed. Therefore, LD50 value was considered to be 464 mg/kg bw, when rabbits were treated with test chemical via dermal route
Thus, based on the above summarized studies on test chemical, it can be concluded that LD50 value is between 200-1000 mg/kg bw. Thus, comparing this value with the criteria of CLP regulation, the given test chemical can be classified for acute dermal toxicity class III.
Justification for classification or non-classification
Based upon the LD50 and LC50 values of test chemical it is observed that the chemical is classified in the following category; Acute oral (category 4), acute inhalation (category 3) and acute dermal (category 3). However, since test chemical has a harmonized classification within the CLP regulation of Acute toxicity category 3 (oral, inhalation and dermal) the same classification shall be adhered to in the classification and labeling section of this dossier.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.